FBIA Comments on FDA Proposed Rule to Revoke Methods of Analysis Regulation

ASTA signed onto a coalition comment letter to the Food and Drug Administration(FDA) in September 2022 on the U.S. Food and Drug Administration (FDA or agency) proposed rule, Revocation of Methods of Analysis Regulation, revoking the methods of analysis regulation, § 2.19 (21 CFR 2.19), which describes an FDA policy to use certain methods of analysis to support FDA enforcement, as needed, and when the method of analysis is not prescribed in a regulation.

Published

09/26/2022 at 5:15 am

Downloads

0